An official website of the United States government
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Atypical Antipsychotics for Schizophrenia: Combination Therapy and High Doses — Project Protocol [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2011 Aug. (CADTH Optimal Use Report, No. 1.1.)
Once a topic is selected, CADTH undertakes activities related to key areas in the procedure. The CAC and ACP provide advice and guidance around topic identification. The OUWG, formed after topic identification, will provide advice and guidance throughout the process, through to supporting intervention and evaluation tools. CERC provides expert advice and recommendations on the topic area relating to the identification, evaluation, and promotion of optimal prescribing and use of drugs. A broad range of stakeholders are invited to provide feedback at key stages in the CADTH process.
This report represents the initial step toward the development of optimal use recommendations for the prescribing and use of combination and high-dose treatment strategies involving AAPs for schizophrenia.
Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/
Your browsing activity is empty.
Activity recording is turned off.
See more...
